Registered entities
Cardioxyl Pharmaceuticals, Inc
Reg. No. 203940469United States
Innovation
14 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 7,202 times.
| Year | Filings |
|---|---|
| 2014 | 6 |
| 2015 | 8 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Investor mix
4 investors on record; lead investors include Orbimed; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |